The effects of 6-hydroxydopamine pretreatment on the accumulation of dopa and dopamine in brain and peripheral organs following L-dopa administration.
D000818:Animals; D001921:Brain / Q000378:metabolism*; D004295:Dihydroxyphenylalanine / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D005753:Gastric Mucosa / Q000378:metabolism*; D006892:Hydroxydopamines / Q000494:pharmacology*; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D009411:Nerve Endings / Q000187:drug effects*; D009638:Norepinephrine / Q000378:metabolism; D010300:Parkinson Disease / Q000378:metabolism; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D013154:Spleen / Q000378:metabolism*; D013564:Sympathetic Nervous System / Q000187:drug effects
D006892:Hydroxydopamines; D012701:Serotonin; D004295:Dihydroxyphenylalanine; D004298:Dopamine; D009638:Norepinephrine